Epidemiology and Outcomes

Hydroxychloroquine availability during COVID-19 crisis and its effect on patient anxiety

Alain Cornet, Jeanette Andersen, Chiara Tani, Marta Mosca

10.1136/lupus-2021-000496

April 19, 2021

Living with systemic lupus erythematosus in 2020: a European patient survey

Alain Cornet, Jeanette Andersen, Kirsi Myllys, Angela Edwards, Laurent Arnaud

10.1136/lupus-2020-000469

April 13, 2021

Smoking associates with distinct clinical phenotypes in patients with systemic lupus erythematosus: a nationwide Danish cross-sectional study

Henrik Christian Bidstrup Leffers, Anne Troldborg, Anne Voss, Salome Kristensen, Jesper Lindhardsen, Prabhat Kumar, Asta Linauskas, Lars Juul, Niels Steen Krogh, Bent Deleuran, Lene Dreyer, Søren Jacobsen

10.1136/lupus-2021-000474

April 2, 2021

Hydroxychloroquine treatment in European patients with lupus erythematosus: dosing, retinopathy screening and adherence

Zgjim Osmani, Thijs J Schrama, Wendy Zacouris-Verweij, Jeanette Andersen, Susan Frankel, Irene E M Bultink, Alain Cornet, Ronald F van Vollenhoven

10.1136/lupus-2021-000478

April 1, 2021

The ALPHA Project: Establishing consensus and prioritisation of global community recommendations to address major challenges in lupus diagnosis, care, treatment and research

Karin Tse, Sanjyot Sangodkar, Lauren Bloch, Kathleen Arntsen, Sang-Cheol Bae, Ian N Bruce, Erin Connolly-Strong, Karen H Costenbader, Bradley Dickerson, Thomas Dörner, Sydney Evans, Kenneth Kalunian, Amy H Kao, Susan Manzi, Eric F Morand, Sandra C Raymond, Brad H Rovin, Laura Eve Schanberg, Joan M Von Feldt, Victoria P Werth, Angel Williams Derricott, David Zook, Timothy Franson, Kenneth Getz, Yaritza Peña, Leslie M Hanrahan

10.1136/lupus-2020-000433

February 9, 2021

Within-trial economic analysis of flare data from the BLISS-SC trial of subcutaneous belimumab in systemic lupus erythematosus

Tasneem Lokhandwala, Binglin Yue, Anna D Coutinho, Christopher F Bell

10.1136/lupus-2020-000438

February 8, 2021

Corticosteroid dosing and opioid use are high in patients with SLE and remain elevated after belimumab initiation: a retrospective claims database analysis

Julie A Birt, Jianmin Wu, Kirstin Griffing, Natalia Bello, Nicole Princic, Isabelle Winer, Carolyn R Lew, Karen H Costenbader

10.1136/lupus-2020-000435

December 23, 2020

Rheumatologists’ perspective on hydroxychloroquine guidelines

James Winebrake, Leila Khalili, Julia Weiner, Yevgeniya Gartshteyn, Lisa Park, Anca D Askanase

10.1136/lupus-2020-000427

November 3, 2020

Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): data from the Peruvian Almenara Lupus Cohort

Manuel Francisco Ugarte-Gil, Rocio Violeta Gamboa-Cardenas, Cristina Reátegui-Sokolova, Victor Román Pimentel-Quiroz, Paola Zeña-Huancas, Claudia Elera-Fitzcarrald, Samira Garcia-Hirsh, Luciana Gil, Cesar Augusto Pastor-Asurza, Zoila Rodriguez-Bellido, Joan Merrill, Anca D Askanase, Graciela Alarcon, Risto Alfredo Perich-Campos

10.1136/lupus-2020-000419

October 12, 2020

Cutaneous vasculitis in SLE

Romy Kallas, Daniel Goldman, Michelle A Petri

10.1136/lupus-2020-000411

September 22, 2020